LAFAYETTE HILL, Pa. (WPVI) -- Pulmonary fibrosis turns the lungs to scar tissue, making it harder and harder to breathe. Help may be on the way, however. A drug being tested locally aims at giving ...
he most common type of lung fibrosis — scarring of the lungs -- is idiopathic, meaning of unknown cause. Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis ...
Why does lung health matter and what is pulmonary fibrosis? The human body has a remarkable ability to heal injury. When one of my sons takes a corner too fast on his bike and scrapes a knee, it ...
Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...
Fibrosis is the body's way of patching up damage—a bit like fixing a pothole. When skin is cut or a muscle is injured, fibroblast cells rush in to make fibronectin and collagen, which are two major ...
Hosted on MSN
Idiopathic pulmonary fibrosis where lung tissue hardens like a scar...Early symptoms are similar to ...
According to data from the Health Insurance Review and Assessment Service in 2023, there are an estimated 15,000 patients with idiopathic pulmonary fibrosis in Korea. Recently, the number of patients ...
A new study has explored the potential of Dextromethorphan, an FDA-approved drug, in the treatment of lung fibrosis. Lung fibrosis occurs after accumulation of scar tissue in the lung (left image ...
AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant ...
The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
Researchers have discovered a pathway by which immune cells prevent the lungs' protective barrier from healing after viral infections like COVID-19. Investigators involved in a multicenter study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results